Case Report: Replacement of PD-1 inhibitors with PD-L1 inhibitors in the treatment of squamous non-small-cell lung carcinoma

BACKGROUND: Immune checkpoint inhibitor (ICI)-associated cardiotoxicity is a relatively uncommon immune-related adverse effects (irAEs) with a high mortality rate. There are few recommendations for the replacement of different immune checkpoint inhibitors in domestic and international reports. CASE...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tong, Li, Yujun, Cui, Xiaonan, Zhang, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465174/
https://www.ncbi.nlm.nih.gov/pubmed/37649479
http://dx.doi.org/10.3389/fimmu.2023.1243980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465174/
https://www.ncbi.nlm.nih.gov/pubmed/37649479
http://dx.doi.org/10.3389/fimmu.2023.1243980

Ejemplares similares